Semaglutide and liraglutide are structurally similar molecules with high selectivity for the GLP-1 receptor, though there are some pharmacologic differences between the two notably, liraglutide has a higher steady state concentration and greater receptor binding affinity than semaglutide, while semaglutide has an increased affinity for serum albumin (thereby improving resistance to degradation) and a longer half-life than liraglutide [38, 61, 62]
Lifestyle Factors That Support Fat Loss in Older Adults Healthy habits make semaglutide more effective
Approximately 72% of GLP-1 receptor agonist prescriptions are dominated by liraglutide and semaglutide combined
Injection Frequency and Timing Inject once per week on the same day each week
The decision to switch medications should always be made with a prescriber based on the full clinical picture, not on genetics alone
The concern is not that GLP-1 medications are dangerous, but rather that the combination of active medication and plasma loss could affect your immediate post-donation recovery